Fig. 2From: Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover studyPatient disposition in studies: (a) 1222.6 and (b) 1222.27Back to article page